Details for Patent: 10,799,138

Which drugs does patent 10,799,138 protect, and when does it expire?

Patent 10,799,138 protects SOTALOL HYDROCHLORIDE and is included in one NDA.

Summary for Patent: 10,799,138

Title:	Method of administering sotalol IV/switch
Abstract:	Embodiments of the invention are broadly drawn to methods for determining an optimum dose of an antiarrhythmic drug, for example sotalol. In particular, the method involves titrating the dose of the drug gradually to determine the optimum plasma concentration for a patient, whether the patient has normal or abnormal renal function.
Inventor(s):	Ivaturi; Vijay (Baltimore, MD), Gobburu; Jogarao (Herndon, VA)
Assignee:	University of Maryland, Baltimore (Baltimore, MD)
Application Number:	16/376,706
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 10,799,138

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Altathera Pharms Llc	SOTALOL HYDROCHLORIDE	sotalol hydrochloride	SOLUTION;INTRAVENOUS	022306-001	Jul 2, 2009		RX	Yes	Yes						INTRAVENOUS SOTALOL DOSING REGIMEN FOR USE IN A FACILITY THAT CAN PROVIDE ELECTROCARDIOGRAPHIC MONITORING
Altathera Pharms Llc	SOTALOL HYDROCHLORIDE	sotalol hydrochloride	SOLUTION;INTRAVENOUS	022306-001	Jul 2, 2009		RX	Yes	Yes						USE FOR LOADING DOSE IN PATIENTS WITH SYMPTOMATIC AFIB/AFL WHO ARE CURRENTLY IN SINUS RHYTHM OR FOR THE TREATMENT OF LIFE-THREATENING VENTRICULAR TACHYCARDIA